Detalles de la búsqueda
1.
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells.
Immunity
; 53(4): 805-823.e15, 2020 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053330
2.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094839
3.
Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients.
Cell Mol Life Sci
; 81(1): 233, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38780775
4.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 25(5): 572-587, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561010
5.
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.
Med J Aust
; 220(2): 80-90, 2024 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38212673
6.
Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programme.
Intern Med J
; 2024 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369719
7.
Nutrition outcomes and treatment toxicities in patients with head and neck cancer receiving helical intensity-modulated radiotherapy.
J Hum Nutr Diet
; 37(1): 182-192, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37737485
8.
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 24(11): 1196-1205, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37875144
9.
Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment.
Br J Nutr
; 129(3): 406-415, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35152926
10.
The changing face of head and neck cancer: are patients with human papillomavirus-positive disease at greater nutritional risk? A systematic review.
Support Care Cancer
; 30(9): 7191-7204, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477809
11.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29863979
12.
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
Lancet Oncol
; 21(9): 1213-1223, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888453
13.
Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma.
Cancer Sci
; 111(10): 3854-3861, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32713038
14.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet
; 394(10212): 1915-1928, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679945
15.
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412.
Future Oncol
; 16(18): 1235-1243, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32490686
16.
Evaluation of a speech pathology service delivery model for patients at low dysphagia risk during radiotherapy for HNC.
Support Care Cancer
; 28(4): 1867-1876, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31352509
17.
Weighted activity unit effect: evaluating the cost of diagnosis-related group coding.
Intern Med J
; 50(4): 440-444, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31111636
18.
Radiotherapy for cutaneous head and neck cancer and parotid tumours: a prospective investigation of treatment-related acute swallowing and toxicity patterns.
Support Care Cancer
; 27(2): 573-581, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019149
19.
The ENHANCES study: a randomised controlled trial of a nurse-led survivorship intervention for patients treated for head and neck cancer.
Support Care Cancer
; 27(12): 4627-4637, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941580
20.
Clinical guidance for radioiodine refractory differentiated thyroid cancer.
Clin Endocrinol (Oxf)
; 88(4): 529-537, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29095527